Document Detail

Seed migration in prostate brachytherapy depends on experience and technique.
MedLine Citation:
PMID:  22543117     Owner:  NLM     Status:  Publisher    
PURPOSE: To determine seed loss and pulmonary migration rate over time in permanent seed prostate brachytherapy. METHODS AND MATERIALS: We analyzed the first 495 patients treated in our department. All patients were treated with loose (125)I seeds with automated seed delivery system and real-time intraoperative planning. Pelvic fluoroscopic imaging was done 30 days after the implant. Patients were divided into five groups of 100 patients according to the order they were treated, and groups were compared using χ(2) test and one-way analysis of variance. RESULTS: A total of 22.8% of patients lost at least one seed. The highest percentage of patients losing any number of seeds was in the first 100. Thirty-eight percent lost at least one seed. This number decreased gradually and was only 9% in Patients 400-499. The mean total seed loss rate (number of seeds lost/number seeds implanted) changed significantly over time (p<0.001). There was a continuous significant (p<0.001) decline after the first 100 patients (1.25% for the first 100 patients) followed by a rise in Patients 300-399, followed by another decline (0.21% for the last 100 patients). The seed loss rate to the thorax changed significantly over time (p=0.009). It rose after an initial rate of 0.25-0.42% in Patients 200-299 and 300-399 and declined later to a rate of 0.21% in the last 100 patients. CONCLUSIONS: We found a learning curve for seed migration. Avoiding implanting seeds outside of the capsule and modern transrectal ultrasound imaging can help decrease migration.
Daniel Taussky; Camille Moumdjian; Renée Larouche; Dominic Béliveau-Nadeau; Chantal Boudreau; Yannick Hervieux; David Donath
Related Documents :
21274877 - Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure.
8438927 - Seeking early medical attention after vaginal bleeding will not assure mild disease in ...
22766997 - Eosinophilic esophagitis: manometric and phmetric findings.
525407 - Percutaneous transperitoneal fluoroscopy-guided fine-needle biopsy of lymph nodes.
15738897 - Disposal of injection material used for the treatment of hepatitis c: comparison with i...
20089347 - The risk of cin ii or greater in a one-year follow-up period in patients with asc-h int...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-27
Journal Detail:
Title:  Brachytherapy     Volume:  -     ISSN:  1873-1449     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137600     Medline TA:  Brachytherapy     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Québec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene ...
Next Document:  [Abnormalities of the testes and semen parameters in clinical varicocele].